Nausea and Vomiting: Common side effects include severe nausea, vomiting, and facial flushing
(1) Microglia release a repertoire of soluble factors [e.g., insulin growth factor-1 (IGF-1), IL-1, TGF-] that facilitate the promotion and prevention of myelination (Hsieh et al., 2004
ATP emit energy signals, ATP-P2RY2 binding is involved in the recruitment of monocytes or macrophages, neutrophils, and promoting DC maturation (19)
It refers to retatrutide, a tripleagonist weightloss medication that activates GLP1, GIP, and glucagon receptors. Early clinical trials show unprecedented weightloss results, often greater than currently approved GLP1 and dualagonist drugs, along with improvements in liver fat and metabolic markers. As research advances and more data become available, medically supervised programs will continue to evaluate where TRIPLEagonist medications fit among GLP1 drugs, dualagonists, peptides, and other tools for sustainable metabolic health